Adaptable Ultrasound-Enhanced Drug Delivery Systems for Specialized Environments

Publication ID: 24-11857459_0009_PTD
Published: October 28, 2025
Category:Specialized Variations & Niche Solutions

Legal Citation

pr1or.art Inc., “Adaptable Ultrasound-Enhanced Drug Delivery Systems for Specialized Environments,” Published Technical Disclosure No. 24-11857459_0009_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857459_0009_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,459.

Summary of the Inventive Concept

The inventive concept disclosed herein relates to specialized ultrasound-enhanced drug delivery systems designed for use in high-security, disaster relief, and extreme weather conditions, providing tailored solutions for unique operational environments.

Background and Problem Solved

The original patent, 'System and method for ultrasound-enhanced delivery of drugs', addresses the need for efficient transscleral delivery of drugs in ophthalmic care. However, it lacks adaptability for use in specific, high-stakes environments. The inventive concept solves this problem by introducing portable, ruggedized, and secure ultrasound-enhanced drug delivery systems for emergency response, high-security, and extreme weather conditions.

Detailed Description of the Inventive Concept

The inventive concept comprises a range of specialized systems, including portable ultrasound-generating devices, waterproof drug applicators, ruggedized control units, and thermally-insulated components. These systems are designed to operate effectively in disaster relief environments, high-security settings, and extreme temperatures. The drug applicators can be coated with antimicrobial agents to reduce infection risks, and the ultrasound-generating devices can be connected to biometric authentication systems to ensure authorized use only. The systems are tailored to address specific challenges in each environment, providing reliable and efficient drug delivery in critical situations.

Novelty and Inventive Step

The inventive concept's novelty lies in its adaptability for use in specialized environments, introducing features such as portability, ruggedization, and security measures that are not present in the original patent. The inventive step resides in the combination of these features with the original ultrasound-enhanced drug delivery technology, resulting in a new class of systems that can effectively operate in high-stakes environments.

Alternative Embodiments and Variations

Alternative embodiments of the inventive concept could include systems designed for use in space exploration, remote wilderness areas, or other extreme environments. Variations could include the integration of advanced sensors, artificial intelligence, or real-time monitoring systems to further enhance the systems' performance and safety.

Potential Commercial Applications and Market

The inventive concept has significant commercial potential in the fields of emergency response, national defense, and extreme environment exploration. The market for these specialized systems is expected to grow as the need for reliable and efficient drug delivery in high-stakes environments increases.

CPC Classifications

SectionClassGroup
A A61 A61F9/0008
A A61 A61M37/0092
A A61 A61F2250/0093

Field of Art

Ophthalmic drug delivery systems, medical device design, ultrasound-enhanced pharmaceutical administration, with expertise in miniaturized medical technologies and drug delivery mechanisms

Person of Ordinary Skill (PHOSITA) Profile

A biomedical engineer or medical device designer with advanced degrees, experience in ultrasound technologies, pharmaceutical formulation, and ophthalmic medical interventions, familiar with adapting medical devices for specialized environments

Obviousness Rationale

A PHOSITA would recognize that the PTD's variations represent predictable extensions of the source patent's core ultrasound-enhanced drug delivery technology by applying known engineering design principles to create environment-specific adaptations. The fundamental mechanism of ultrasound-assisted drug delivery remains consistent, with the PTD introducing contextual modifications that would be considered routine problem-solving for a skilled practitioner. The technical solutions proposed are logical adaptations addressing known challenges in specialized medical delivery scenarios.

Obvious Combinations & Variations

Source Patent Element
Drug applicator with exchangeable/single-use configuration
PTD Variation
Waterproof and antimicrobial-coated drug applicator for disaster relief environments
Obviousness Reasoning
Extending single-use design concept with additional protective features represents a predictable modification addressing environmental challenges, using known materials science techniques
Source Patent Element
Ultrasound transducer with signal generating unit and controller
PTD Variation
Compact, battery-powered ultrasound device with biometric authentication
Obviousness Reasoning
Adding security and portability features represents a standard design evolution using known electronic integration techniques, motivated by increasing demand for secure medical technologies
Source Patent Element
Scleral drug delivery system with coupling mechanisms
PTD Variation
Temperature-controlled drug applicator with thermal insulation for extreme environments
Obviousness Reasoning
Modifying drug delivery interface to maintain pharmaceutical stability is a predictable solution using established thermal management principles in medical device design
Source Patent Element
Ultrasound-enhanced drug delivery targeting intraocular spaces
PTD Variation
Specialized systems for high-security and disaster relief contexts with encrypted delivery mechanisms
Obviousness Reasoning
Adapting core drug delivery technology to specific operational contexts represents standard engineering problem-solving, using known encryption and environmental adaptation techniques
35 U.S.C. § 103 Summary: Based on the teachings of US Patent 11857459, a person having ordinary skill in the art would find the variations disclosed in the Published Technical Disclosure to represent obvious modifications to the fundamental ultrasound-enhanced drug delivery technology. The proposed adaptations constitute predictable engineering solutions that would be readily conceived by a skilled practitioner seeking to extend the original invention's applicability to specialized medical environments, thus rendering potential derivative claims obvious under 35 U.S.C. ยง 103.

Original Patent Information

Patent NumberUS 11,857,459
TitleSystem and method for ultrasound-enhanced delivery of drugs
Assignee(s)SONIKURE HOLDINGS LIMITED